Castiglione-Gertsch M - Search Results

1

Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.

Bernhard J, Peterson HF, Coates AS, Gusset H, Isley M, Hinkle R, Gelber RD, Castiglione-Gertsch M, Hürny C. Bernhard J, et al. Stat Med. 1998 Mar 15-Apr 15;17(5-7):587-601. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<587::aid-sim806>3.0.co;2-#. Stat Med. 1998. PMID: 9549808

2

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.

Hürny C, Bernhard J, Coates AS, Castiglione-Gertsch M, Peterson HF, Gelber RD, Forbes JF, Rudenstam CM, Simoncini E, Crivellari D, Goldhirsch A, Senn HJ. Hürny C, et al. Lancet. 1996 May 11;347(9011):1279-84. doi: 10.1016/s0140-6736(96)90936-8. Lancet. 1996. PMID: 8622502 Clinical Trial.

3

Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.

Hürny C, Bernhard J, Coates A, Peterson HF, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Collins J, Lindtner J, Goldhirsch A, Senn HJ. Hürny C, et al. Med Care. 1996 Mar;34(3):234-48. doi: 10.1097/00005650-199603000-00004. Med Care. 1996. PMID: 8628043 Clinical Trial.

4

Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.

Bernhard J, Hürny C, Coates AS, Peterson HF, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Senn HJ, Rudenstam CM. Bernhard J, et al. Ann Oncol. 1997 Sep;8(9):825-35. doi: 10.1023/a:1008269715091. Ann Oncol. 1997. PMID: 9358933 Free article. Clinical Trial.

5

Adjuvant systemic therapy: the issues of timing and sequence.

Castiglione-Gertsch M, Gelber RD, Goldhirsch A. Castiglione-Gertsch M, et al. Recent Results Cancer Res. 1996;140:201-13. doi: 10.1007/978-3-642-79278-6_23. Recent Results Cancer Res. 1996. PMID: 8787063 Review. No abstract available.

6

Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.

Castiglione-Gertsch M, Tattersall M, Hacking A, Goldhirsch A, Gudgeon A, Gelber RD, Lindtner J, Coates A, Collins J, Isley M, Senn HJ, Rudenstam CM. Castiglione-Gertsch M, et al. Eur J Cancer. 1997 Dec;33(14):2321-5. doi: 10.1016/s0959-8049(97)10011-9. Eur J Cancer. 1997. PMID: 9616275

7

Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).

Bernhard J, Hürny C, Coates AS, Peterson HF, Castiglione-Gertsch M, Gelber RD, Galligioni E, Marini G, Thürlimann B, Forbes JF, Goldhirsch A, Senn HJ, Rudenstam CM. Bernhard J, et al. Br J Cancer. 1998 Sep;78(5):686-93. doi: 10.1038/bjc.1998.561. Br J Cancer. 1998. PMID: 9744512 Free PMC article.

8

Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil. International Breast Cancer Study Group.

Colleoni M, Price KN, Castiglione-Gertsch M, Gelber RD, Coates AS, Goldhirsch A. Colleoni M, et al. Lancet. 1999 Jul 10;354(9173):130-1. doi: 10.1016/s0140-6736(99)02015-2. Lancet. 1999. PMID: 10408495 Clinical Trial.

9

Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK).

Bernhard J, Castiglione-Gertsch M, Schmitz SF, Thürlimann B, Cavalli F, Morant R, Fey MF, Bonnefoi H, Goldhirsch A, Hürny C. Bernhard J, et al. Eur J Cancer. 1999 Jun;35(6):913-20. doi: 10.1016/s0959-8049(99)00028-3. Eur J Cancer. 1999. PMID: 10533471 Clinical Trial.

10

Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?

Bernhard J, Thürlimann B, Schmitz SF, Castiglione-Gertsch M, Cavalli F, Morant R, Fey MF, Bonnefoi H, Goldhirsch A, Hürny C. Bernhard J, et al. J Clin Oncol. 1999 Jun;17(6):1672-9. doi: 10.1200/JCO.1999.17.6.1672. J Clin Oncol. 1999. PMID: 10561203 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page